ClinicalTrials.gg
RecruitingNCT07181967StreptococcusUpdated Nov 18, 2025

SDF vs Fluoride Varnish for Streptococcus Mutans Reduction in Children

An interventional study of Sodium Fluoride Varnish (5%) and Silver Diamine Fluoride (38%) in Dental Caries, sponsored by Assiut University. Recruiting at 1 site in Egypt. Open to participants aged 3 Years to 8 Years. Per ClinicalTrials.gov, last updated 2025-11-18.

Sponsored by Assiut University · Not applicable, Interventional, and Prevention

How we know

From the registry’s dates

  • Primary completion was expected by Dec 2025, 11 months ago, but the record still lists the study as recruiting.
  • Started Sep 2025; still recruiting 1 year 2 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
48
Allocation
Randomized
Ages
3 Years to 8 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 26 studies testing silver diamine fluoride in Dental Caries — 4 open to participants now, 4 under way, none of them phase 3. silver diamine fluoride · Dental Caries.

Planned enrollment
19th of 26
48 · median 60
Started
2025
with 2 others
No phase
6 of 26
2 open now
Registered
21st of 26
by date
Lead sponsor
1 of 26
Assiut University

Among the 26 studies testing silver diamine fluoride in Dental Caries, this one is the 19th largest by planned enrollment, is one of 3 that started in 2025, is one of 6 with no phase, and was the 21st registered.

Dental Caries

1,176 studies on the registry are indexed under Dental Caries; 209 are open to participants now.

Browse Dental Caries studies →

Open to participants now

4 of the 26 studies testing silver diamine fluoride in Dental Caries are open now, in 3 countries. Recruiting first, the newest first:

By country, each count listing its studies:

All 4 open studies →

About silver diamine fluoride

No approval found in the FDA or EMA files read. How studies give it is on its page →

Who these studies take

Of the 86 Dental Caries studies recruiting now, 18 (21%) set no upper age limit and 66 (77%) stop at 75 or younger; 60 take children under 18; 53 take healthy volunteers.

This study: 3 Years to 8 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 26 studies testing silver diamine fluoride in Dental Caries, or all of them as a file.
02

Study summary

This randomized split-mouth clinical trial will compare the effectiveness of 38% silver diamine fluoride (SDF) versus 5% sodium fluoride varnish (FV) in reducing salivary Streptococcus mutans levels in children with bilateral caries. Each participant will receive SDF on one side of the mouth and FV on the contralateral side. The primary outcome is change in Dentocult SM Strip Mutans scores in plaque over 3 months. Secondary outcomes include plaque index, bleeding on probing, and adverse events.

03

Conditions studied

  • Dental Caries

Keywords

  • Silver Diamine Fluoride; Fluoride Varnish; Streptococcus mutans; Dental Plaque
04

Who can participate

Ages eligible
3 Years to 8 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 3-8 years; cooperative (Frankl ≥2).
  • ≥2 contralateral primary molars with active dentin caries (ICDAS 3-5) of comparable severity.
  • Parent/guardian consent; child assent when appropriate.

Exclusion criteria

Exclusion Criteria:

  • Silver allergy; ulcerative gingivitis/stomatitis.
  • Systemic antibiotics within 4 weeks.
  • Fixed appliances interfering with plaque assessment.
  • Conditions precluding safe participation per clinician judgment.
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Outcomes assessor)
Enrollment
48 participants (estimated)

Study arms

  • Experimental
    Silver Diamine Fluoride (SDF)

    Application of 38% silver diamine fluoride (44,800 ppm F) to all eligible dentin caries lesions on the assigned side of the mouth. Single application per manufacturer's instructions.

    Drug: Silver Diamine Fluoride (38%)

  • Active comparator
    Fluoride Varnish (FV)

    Application of 5% sodium fluoride varnish (22,600 ppm F) to all eligible dentin caries lesions on the contralateral side of the mouth. Single application per manufacturer's instructions.

    Drug: Sodium Fluoride Varnish (5%)

Interventions

  • DrugSodium Fluoride Varnish (5%)

    Topical application of 5% sodium fluoride varnish (22,600 ppm fluoride) to cavitated dentin caries lesions (ICDAS 3-5) on the contralateral side of the mouth. Applied once using a disposable applicator per manufacturer's instructions. This distinguishes it from lower-concentration fluoride gels or multiple-application protocols in other clinical trials.

  • DrugSilver diamine fluorideStudies of Silver diamine fluorideSilver diamine fluoride pageHow we knowJudged by ClinicalTrials.gg, not part of the registry record.

    Topical application of 38% silver diamine fluoride solution (44,800 ppm fluoride) to cavitated dentin caries lesions (ICDAS 3-5) on the assigned side of the mouth. Applied once with a microbrush for 1 minute, per manufacturer's instructions, without subsequent rinsing. This concentration and protocol distinguish it from other concentrations of SDF or repeated-application protocols used in other clinical studies."

06

What researchers measure

Primary outcomes

  1. Change in Streptococcus mutans levels measured by Dentocult SM Strip Mutans test at baseline, 1 week, 1 month, and 3 months

    Streptococcus mutans levels will be assessed using the Dentocult SM Strip Mutans test (Orion Diagnostica/Aidian). The test provides a semi-quantitative estimate of salivary S. mutans based on colony density on a selective culture strip.

    Time frame: 3 month

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Sep 2025 (actual). Primary completion is estimated for Dec 2025, 3 months after the start.

Of 470 non-industry interventional studies with no phase under Dental Caries, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 30. This study's planned 3 months is below that.

Counting every sponsor, half of 503 studies reached it within 15 months; a quarter within 7 and three quarters within 29.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 9, 2025
First posted
Sep 19, 2025
StartActual
Sep 15, 2025
Primary completionEst.
Dec 15, 2025
CompletionEst.
Dec 30, 2025
Last update
Nov 18, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Nov 18, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07181967
Lead sponsor
Assiut University
Responsible party
ِAhmed kamel Abdel Naser soliman (Assistant Lecturer, Assiut University) — Principal investigator
First posted
Sep 19, 2025
Start date
Sep 15, 2025
Primary completion
Dec 15, 2025 (estimated)
Completion
Dec 30, 2025 (estimated)
Last update
Nov 18, 2025

Study contacts

ِAhmed Kamel soliman, PHD
Contact
a.k.soliman@hotmail.com
+201061553007

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Silver diamine fluoride

Start the discussion